Robust and versatile technologies that enable optical modulation of transcription in the mammalian endogenous genome have been difficult to achieve for a while. To solve this problem, scientists at the Broad Institute of MIT and Harvard developed light-inducible transcriptional effectors (LITEs) — an optogenetic two-hybrid system integrating the TALE DNA-binding domain with a light-sensitive cryptochrome 2 protein and its partner CIB1 from the Arabidopsis thaliana plant.
LITEs can be customized to target many endogenous genomic loci and can be quickly activated with reversibility, while not requiring any additional exogenous chemical co-factors. Furthermore, LITEs can probe specific cell populations by genetic targeting and be packaged into viral vectors. They have applied this system in primary mouse neurons and in the brain of freely behaving mice in vivo, to “mediate reversible modulation of mammalian endogenous gene expression as well as targeted epigenetic chromatin modifications.”
The LITE system is a novel method of optogenetic control of endogenous cellular processes which can enable direct testing of genetic and epigenetic regulation in both normal and disease states.
For more details, see the published article (Nature 500, 472–476, Aug, 2013).
Skincare has been moving steadily away from one-size-fits-all routines and toward measurement-led personalization. One reason…
Consumers often describe a familiar problem: skin that seems to lose firmness, glow, and smoothness…
Autophagy is the eukaryotic cell’s waste management system; it collects and recycles damaged organelles and…
For decades, scientists have been unraveling the intricate mechanisms that govern gene expression. While DNA…
“To lengthen thy life, lessen thy meals.” - Benjamin Franklin. For millennia, fasting has been…
With the rising prevalence and legalization of cannabis worldwide, understanding its biological impact—especially on mental…